[{"data":1,"prerenderedAt":436},["ShallowReactive",2],{"tool-healthcare-yaozh":3,"footer-total":410,"related-healthcare-yaozh":411},{"id":4,"title":5,"author":6,"bestFor":7,"body":8,"category":367,"cons":368,"cover":374,"date":375,"description":376,"draft":377,"extension":378,"meta":379,"navigation":380,"notFor":381,"path":382,"pricing":383,"pros":387,"region":393,"score":394,"scoreBreakdown":395,"seo":401,"stem":402,"tags":403,"toolName":218,"updated":375,"url":407,"vendor":408,"__hash__":409},"tools\u002Ftools\u002Fhealthcare\u002Fyaozh.md","药智网 评测","元析评测","药企研发、注册与 BD 岗,以及做仿制药立项、一致性评价跟进和批文尽调的团队",{"type":9,"value":10,"toc":340},"minimark",[11,15,23,26,29,51,54,59,62,65,69,72,75,79,82,85,88,92,95,99,102,106,109,113,116,120,123,126,201,204,207,297,303,307,311,314,318,321,325,328,331,334],[12,13,14],"h2",{"id":14},"结论先行",[16,17,18,22],"p",{},[19,20,21],"strong",{},"推荐,总分 8.1;专业版与企业版都没有公开价目,按年议价,先申请试用再谈合同。"," 药智网是本轮八家里产品线最杂的一家:药品数据、医械数据、专利通、销售数据、供应链、咨询、AI 工具分属不同子域,每块单独卖。研发和注册岗最常用的是药智数据里的注册申报、一致性评价进度与说明书,字段细到受理号、审评状态、办理状态,做批文尽调时能一层层往下翻。",[16,24,25],{},"短板也来自这个结构。想一次买齐,要跨六七个站点、签几份合同,账号还不互通;而官网只挂试用入口,不挂价格,预算得等销售给方案。2026-11 我们看官网时,专业版与企业版的功能差异要用试用权限才能看清。",[12,27,28],{"id":28},"这篇评测基于什么数据",[30,31,32,36,39,42,45,48],"ul",{},[33,34,35],"li",{},"官网首页(2026-11 核对):产品线导航,含药智数据、医械数据、专利通、销售数据、药智通、开放平台、AI 平台",[33,37,38],{},"药智数据页面结构:专业版与企业版两级,全球药物、市场全终端销售数据、药品市场预测等作为独立入口",[33,40,41],{},"官网报告中心(2026-11):2026 年 9 月一致性评价分析报告记 252 个药品通过或视同通过一致性评价",[33,43,44],{},"医械侧公开数据:2026 年上半年中国医疗器械进出口 2568.00 亿元,出口 1558.90 亿元",[33,46,47],{},"定价:官网只有试用与咨询入口,未公布价目",[33,49,50],{},"实测说明:未购买企业版做全库验证,以下功能判断来自公开页面、试用入口说明与报告样例,未做统一环境实测",[12,52,53],{"id":53},"核心功能",[55,56,58],"h3",{"id":57},"注册与一致性评价这条线最扎实","注册与一致性评价:这条线最扎实",[16,60,61],{},"药智数据的核心是药品注册全链条。中国上市药品库按批文组织,能查到批准文号、剂型、规格、企业、一致性评价状态;申报与审评库跟药审中心的受理号绑定,含注册分类、办理状态、审评结果与排队序列。做仿制药立项,先在参比制剂目录里定位原研,再对一遍国内过评企业数,基本能判断这个品种还剩多少窗口。",[16,63,64],{},"一致性评价进度是它长期做的栏目,官网按月出分析报告,把过评企业数、首家过评、视同过评分开统计。",[55,66,68],{"id":67},"医械与专利两条独立产品线","医械与专利:两条独立产品线",[16,70,71],{},"医械数据(qx.yaozh.com)覆盖国产二类三类注册、医用耗材中标、带量采购、全球器械说明书,同样分专业版与企业版。它和药品库不共用账号,采购时要单独谈。",[16,73,74],{},"专利通是另一个独立站,做专利检索与法律状态跟踪。药品专利到期判断常用它,但与药智数据的字段没有做深度关联,想看\"某专利到期后国内谁在申报\"要手工拼两次结果。",[55,76,78],{"id":77},"供应链与-ai-工具免费入口引流","供应链与 AI 工具:免费入口引流",[16,80,81],{},"药智通是供应链平台,供应商可免费开店,采购方可直接对参比制剂、杂质对照品、中间体、CRO 服务发起询价。对做研发采购的人,这个入口比逐个加供应商微信省事,但报价质量取决于供应商活跃度。",[16,83,84],{},"AI 平台已把几个高频场景做成成品:仿制药品种评估、药物管线分析报告、成药性预测。用法是填参数出报告,适合快速摸底,不适合当立项唯一依据。官网上还有开放平台,提供接口给企业系统调用。",[12,86,87],{"id":87},"评分明细",[55,89,91],{"id":90},"功能完整度8610","功能完整度:8.6\u002F10",[16,93,94],{},"从注册申报、一致性评价、说明书、专利到医械与供应链,一张研发流程图上的环节基本都能找到对应库。扣分在终端销售与真实世界数据,这两块它做得比专门做零售监测的厂商浅。",[55,96,98],{"id":97},"易用性8010","易用性:8.0\u002F10",[16,100,101],{},"单库检索好上手,筛选条件按药审语言组织,注册岗几乎不用学。扣分在跨站跳转,同一个品种在数据、专利、医械三个站要各查一遍,导航层级也偏深。",[55,103,105],{"id":104},"数据质量8210","数据质量:8.2\u002F10",[16,107,108],{},"注册与审评数据与官方口径对得上,字段规范,历史版本齐全。扣分在更新时差与部分库的字段缺失,药审中心集中放量时,新受理号进库会慢几天。",[55,110,112],{"id":111},"性价比7610","性价比:7.6\u002F10",[16,114,115],{},"单看一个库不算贵,想覆盖研发全流程就要买三四条产品线,总价上去了。企业版按账号数计价,分析师多的团队人均成本会被摊薄,小团队则容易买多了用不满。",[55,117,119],{"id":118},"客户支持7910","客户支持:7.9\u002F10",[16,121,122],{},"试用流程顺,销售响应快,报告中心与资讯栏目免费内容多,遇到字段疑问能找到说明。扣分在跨产品线的售后要分别找对应团队,一个问题常被转两手。",[12,124,125],{"id":125},"定价说明",[127,128,129,145],"table",{},[130,131,132],"thead",{},[133,134,135,139,142],"tr",{},[136,137,138],"th",{},"产品线",[136,140,141],{},"价格",[136,143,144],{},"说明",[146,147,148,160,170,180,191],"tbody",{},[133,149,150,154,157],{},[151,152,153],"td",{},"药智数据专业版",[151,155,156],{},"未公开",[151,158,159],{},"按账号与库范围议价,官网提供试用",[133,161,162,165,167],{},[151,163,164],{},"药智数据企业版",[151,166,156],{},[151,168,169],{},"面向企业多账号,含数据接口与定制字段",[133,171,172,175,177],{},[151,173,174],{},"医械数据 \u002F 专利通",[151,176,156],{},[151,178,179],{},"独立站点,单独签约",[133,181,182,185,188],{},[151,183,184],{},"药智通供应链",[151,186,187],{},"免费入驻",[151,189,190],{},"供应商开店免费,采购询价不收费",[133,192,193,196,198],{},[151,194,195],{},"定制报告与咨询",[151,197,156],{},[151,199,200],{},"按项目报价,报告中心另有标准报告",[16,202,203],{},"2026-11 核对官网,所有付费线都只给试用入口,没有价目表。真正影响总价的是三件事:买几条产品线、账号怎么分、要不要接口。销售常把\"全库打包\"作为默认方案,但研发团队实际高频用的往往只有注册申报、一致性评价、说明书三个库,先按需买能省下不少。合同里要写清账号是否允许同部门多人轮用,以及历史数据的回溯年限。",[12,205,206],{"id":206},"和竞品对比",[127,208,209,225],{},[130,210,211],{},[133,212,213,216,219,222],{},[136,214,215],{},"维度",[136,217,218],{},"药智网",[136,220,221],{},"米内网",[136,223,224],{},"医药魔方",[146,226,227,241,255,269,283],{},[133,228,229,232,235,238],{},[151,230,231],{},"主打",[151,233,234],{},"药品研发与注册情报",[151,236,237],{},"终端销售与市场格局",[151,239,240],{},"全球新药情报与投融资",[133,242,243,246,249,252],{},[151,244,245],{},"起步价",[151,247,248],{},"未公开,分专业版与企业版",[151,250,251],{},"未公开,按年议价",[151,253,254],{},"未公开,按模块议价",[133,256,257,260,263,266],{},[151,258,259],{},"强项",[151,261,262],{},"受理号级注册数据、一致性评价、医械",[151,264,265],{},"医院与药店终端销售额",[151,267,268],{},"管线、临床试验、BD 交易",[133,270,271,274,277,280],{},[151,272,273],{},"产品形态",[151,275,276],{},"多子站,单库售卖",[151,278,279],{},"单站,模块授权",[151,281,282],{},"多产品,按角色切分",[133,284,285,288,291,294],{},[151,286,287],{},"短板",[151,289,290],{},"账号分散、终端销售弱",[151,292,293],{},"研发字段浅",[151,295,296],{},"中文终端数据弱",[16,298,299,302],{},[19,300,301],{},"怎么选",":工作是跟注册申报、一致性评价、批文尽调打交道,选药智网;要算品类在院内院外的销售额,选米内网;做创新药立项与 BD 标的筛选,选医药魔方。药智网与米内网经常一起买,前者看\"能不能批\",后者看\"卖了多少\",两边字段不重叠。",[12,304,306],{"id":305},"faq","FAQ",[55,308,310],{"id":309},"q-药智网到底贵不贵有没有个人版","Q: 药智网到底贵不贵,有没有个人版?",[16,312,313],{},"A: 有面向个人的专业版,按年付费,价格随选库不同而变,官网不公示。个人研究者如果只查说明书和批文,先用免费检索能覆盖大半需求;需要导出和批量筛选再考虑付费。企业版按账号数计价,通常要求一次性买多个席位。",[55,315,317],{"id":316},"q-药智通是免费的吗","Q: 药智通是免费的吗?",[16,319,320],{},"A: 供应商入驻开店免费,采购方询价也免费,平台不做撮合抽成。付费点在曝光位与增值服务,比如优质供应商排序。询价质量取决于供应商是否在线,冷门对照品可能几天没人回,急单建议同时找线下渠道。",[55,322,324],{"id":323},"q-医械数据和药品数据能用一个账号吗","Q: 医械数据和药品数据能用一个账号吗?",[16,326,327],{},"A: 不能。医械数据是独立站点,账号与药品库不互通,买两块要分别签约。两边都做的人,常见做法是申请一个企业版打包,让销售把两条线并进同一份合同,权限仍分开管理。",[12,329,330],{"id":330},"评测方法说明",[16,332,333],{},"元析评测围绕功能完整度、易用性、数据质量、性价比、客户支持五个维度打分,每项满分 10 分,加权折算总分。药智网的产品线清单、报告数据与试用入口核对于 2026-11,付费产品均无公开价目,文中金额一律留空。我们申请了公开试用入口但未签企业合同,多账号协作与接口调用的体验描述来自官网说明。",[16,335,336,339],{},[19,337,338],{},"最后更新",":2026-11-16",{"title":341,"searchDepth":342,"depth":342,"links":343},"",2,[344,345,346,352,359,360,361,366],{"id":14,"depth":342,"text":14},{"id":28,"depth":342,"text":28},{"id":53,"depth":342,"text":53,"children":347},[348,350,351],{"id":57,"depth":349,"text":58},3,{"id":67,"depth":349,"text":68},{"id":77,"depth":349,"text":78},{"id":87,"depth":342,"text":87,"children":353},[354,355,356,357,358],{"id":90,"depth":349,"text":91},{"id":97,"depth":349,"text":98},{"id":104,"depth":349,"text":105},{"id":111,"depth":349,"text":112},{"id":118,"depth":349,"text":119},{"id":125,"depth":342,"text":125},{"id":206,"depth":342,"text":206},{"id":305,"depth":342,"text":306,"children":362},[363,364,365],{"id":309,"depth":349,"text":310},{"id":316,"depth":349,"text":317},{"id":323,"depth":349,"text":324},{"id":330,"depth":342,"text":330},"healthcare",[369,370,371,372,373],"产品线太散,数据、医械、专利、供应链、咨询各占一个子域,账号与权限不互通,买齐要签好几份合同","官网不标价,专业版与企业版的差别只在功能清单,预算要等销售给方案","终端销售数据的覆盖与口径不如专门做医院、药店零售监测的厂商细","免费内容与付费库混在同一导航里,新用户常点进付费页才发现要权限","部分库的更新节奏跟审评节奏走,药审中心集中放量时数据会滞后几天",null,"2026-11-16","药智网评测:库多、入口散,专业版与企业版均无公开价目、按年议价;一致性评价与注册申报数据细到受理号,适合研发与注册岗;想一次买齐要跨六七个站点,账号体系不统一。",false,"md",{},true,"只想看终端销售额排名、做零售渠道分析的市场部,以及预算极低的个人研究者","\u002Ftools\u002Fhealthcare\u002Fyaozh",{"free":377,"startingPrice":341,"currency":384,"billingPeriod":385,"notes":386},"CNY","年","药智数据分专业版与企业版,另有全球药物、专利通、医械数据、销售数据等独立产品线,各线单独报价;官网有免费试用入口,但未公布价目表。官网未公开报价,需联系销售。价格于 2026-11 核对官网。",[388,389,390,391,392],"药智数据按药品、医械、销售、专利四条线拆分,注册申报与一致性评价字段细到受理号与审评状态","公开数据可交叉印证,官网报告中心每月发布一致性评价分析报告,2026 年 9 月记 252 个药品过评","药智通把供应链询价拉进同一平台,参比制剂、杂质对照品、原料药可直接向供应商问价,入驻免费","有开放平台与 APP,常用库能在手机上看,接口可对接企业内部系统","AI 侧已上线仿制药品种评估、药物管线分析报告等成品,不用自己拼字段","cn",8.1,{"features":396,"ease":397,"data":398,"price":399,"support":400},8.6,8,8.2,7.6,7.9,{"title":5,"description":376},"tools\u002Fhealthcare\u002Fyaozh",[404,405,406,218],"医疗健康","医药数据","研发情报","https:\u002F\u002Fwww.yaozh.com","重庆康洲大数据(集团)有限公司","BoKMg26RB3y7AADog4RAjTuevSGXtdBLbAhMD2_qg78",1016,[412,420,428],{"path":413,"toolName":414,"description":415,"score":396,"pricing":416,"vendor":418,"date":419,"category":367},"\u002Ftools\u002Fhealthcare\u002Fdxy","丁香医生","丁香医生是丁香园旗下院外健康平台,集团官网写明注册医师 450 万+,App 首次问诊 9.9 元起,科普内容有医生审稿。它适合药企做患者教育、个人问小病,不适合当医院信息系统用,也不做医保结算,问诊只是轻咨询。",{"free":380,"startingPrice":341,"currency":384,"billingPeriod":385,"notes":417},"C 端免费使用,问诊按次付费,App Store 官方文案写明首次问诊 9.9 元起,复诊单价由接诊医生设定。药企内容合作、医院科普项目等机构业务官网未公开标准报价,需联系销售。价格核对时间 2026-11。","丁香园","2026-11-04",{"path":421,"toolName":422,"description":423,"score":424,"pricing":425,"vendor":422,"date":427,"category":367},"\u002Ftools\u002Fhealthcare\u002Falihealth","阿里健康","阿里健康是阿里系医药与医疗平台,官网披露天猫健康 4.83 万商家、大药房 123 万 SKU、码上放心服务 7100 家流通企业。强项在商家规模与药品追溯合规,适合药企做渠道,不适合想买独立 HIS 的医院,云医院由合作方实施。",8.5,{"free":377,"startingPrice":341,"currency":384,"billingPeriod":385,"notes":426},"C 端购药与问诊按件、按次付费,无独立订阅套餐。天猫健康入驻涉及保证金与技术年费,码上放心按追溯码用量或年度服务计费,官网均未公开标准报价,需联系销售。价格核对时间 2026-11。","2026-10-22",{"path":429,"toolName":430,"description":431,"score":432,"pricing":433,"vendor":430,"date":435,"category":367},"\u002Ftools\u002Fhealthcare\u002Fhaodf","好大夫在线","好大夫在线收录 10450 家医院、931617 位大夫,App 写明 28 万医生入驻、服务 8900 万患者。它是医生个人品牌的入口,问诊价格由医生定,适合副主任以上医生和找专病专家的患者。不适合急诊,入驻免费但抽成不公开,签约前要多看同城案例。",8.3,{"free":380,"startingPrice":341,"currency":384,"billingPeriod":385,"notes":434},"患者浏览医生主页、看评价免费,图文、电话、视频问诊按医生自报价付费,私人医生与优选会员为付费服务。医生入驻不收费。平台抽成比例与机构合作报价官网未公开标准报价,需联系销售。价格核对时间 2026-11。","2026-10-29",1794788233096]